| Literature DB >> 28784934 |
André Luiz Bandeira Dionizio Cardoso1,2, Éric Heleno Freire Ferreira Frederico2,3, Carlos Alberto Sampaio Guimarães2, Lívia Pinto Almeida2, Rosane de Figueiredo Neves2, Danúbia Cunha de Sá-Caputo2, Eloá Moreira-Marconi2,4, Carla de Fontoura Dionello5,2, Danielle Soares Morel5,2, Laisa Liane Paineiras-Domingos5,2, Cintia Renata Sousa-Gonçalves5,2, Nasser Ribeiro Asad2, Mario Bernardo-Filho2.
Abstract
The consequences of treatment involving the use of a natural product and whole body vibration (WBV) exercise have been investigated. The aim of the present study was to evaluate the effects of the joint treatment with an aqueous extract of Chenopodium ambrosioides and WBV on physiological parameters in rats. Wistar rats (n=20) were divided equally into four groups: control group (CG), treated with C. ambrosioides (CHE) group, exposed to 50 Hz of mechanial vibration (VBR), and treated with C. ambrosioides and exposed to 50 Hz of mechanical vibration (VBR + CHE) daily for 6 weeks. The body mass of the animals was determined weekly, the feed intake and the stool consistency were measured daily. One day after the 6 weeks of treatment, samples of blood were collected and used for biochemical analysis. Along 6 weeks, there was an increase (P<0.001) in the feed intake in VBR group and a decrease in the CHE group in comparison with other groups. The levels of the enzyme aspartate aminotransferase (AST) in VBR + CHE group decreased (P<0.05) in comparison with other groups. No differences were found in body mass and stool consistency. WBV altered the feed intake without directly affecting the body mass. Moreover, WBV in association with C. ambrosioides caused alteration in the enzymatic activity of AST.Entities:
Keywords: Chenopodium ambrosioides; body mass; enzymatic activity; feed intake; physiological parameters; whole body vibration
Mesh:
Substances:
Year: 2017 PMID: 28784934 PMCID: PMC5563538 DOI: 10.1042/BSR20170846
Source DB: PubMed Journal: Biosci Rep ISSN: 0144-8463 Impact factor: 3.840
Figure 1Wistar rats from CG, CHE, VBR, VBR + CHE
Figure 2Spectrophotometry of C. ambrosioides aqueous extract at 15 mg/ml
Body mass (%) of the groups of animals submitted to different treatments
| Week | CG (%) | CHE (%) | VBR (%) | VBR + CHE (%) | ||
|---|---|---|---|---|---|---|
| 0 | 100.00 ± 0.00 | 100.00 ± 0.00 | 100.00 ± 0.00 | 100.00 ± 0.00 | 0.0000 | 0.0000 |
| 2 | 102.60 ± 4.96 | 102.44 ± 6.71 | 98.98 ± 2.61 | 100.32 ± 3.31 | 0.8315 | 0.0460 |
| 3 | 105.67 ± 4.50 | 106.03 ± 6.30 | 101.55 ± 2.60 | 102.25 ± 3.20 | 0.6007 | 0.0982 |
| 4 | 109.02 ± 4.89 | 109.52 ± 8.35 | 104.92 ± 1.01 | 104.60 ± 5.53 | 0.7302 | 0.0682 |
| 5 | 111.93 ± 4.91 | 112.46 ± 6.92 | 108.48 ± 2.17 | 105.72 ± 5.35 | 0.3896 | 0.1586 |
| 6 | 115.27 ± 4.40 | 113.72 ± 6.93 | 110.84 ± 2.04 | 109.03 ± 7.11 | 0.6077 | 0.0965 |
‘0’ was the first measurement of the mass of the animals. Values are shown as the median ± S.D., P, ɛ2.
Figure 3Effects of WBV on feed intake
Values are mean ± S.D.; **P<0.001, ***P<0.0001.
Stool consistency of animals submitted to different treatments following a Frederico scale adapted for Wistar rats
| Day | CG | CHE | VBR | VBR + CHE | ||
|---|---|---|---|---|---|---|
| 1–10 | 2.00 ± 0.67 | 2.00 ± 0.42 | 2.00 ± 0.47 | 2.00 ± 0.47 | 0.9835 | 0.0085 |
| 11–20 | 2.00 ± 0.11 | 2.00 ± 0.32 | 2.00 ± 0.58 | 2.00 ± 0.52 | 0.1485 | 0.2810 |
| 21–30 | 2.00 ± 0.00 | 2.00 ± 0.19 | 2.00 ± 0.44 | 2.00 ± 0.16 | 0.1000 | 0.0000 |
| 31–40 | 2.00 ± 0.00 | 2.00 ± 0.00 | 2.00 ± 0.14 | 2.00 ± 0.00 | >0.05 | 0.0000 |
Values are shown as the median ± S.D., P, ɛ2.
Plasma concentration of some biomarkers in animals submitted to different treatments
| Biomarkers | CG | CHE | VBR | VBR + CHE | ||
|---|---|---|---|---|---|---|
| Cholesterol (mmol/l) | 1.37 ± 0.26 | 1.15 ± 0.18 | 1.42 ± 0.19 | 1.36 ± 0.07 | 0.1309 | 0.1882 |
| Triglyceride (mmol/l) | 0.76 ± 0.31 | 0.66 ± 0.26 | 0.94 ± 0.35 | 1.00 ± 0.40 | 0.3109 | 0.2965 |
| HDL (mmol/l) | 1.33 ± 0.18 | 1.17 ± 0.22 | 1.34 ± 0.14 | 1.29 ± 0.07 | 0.5846 | 0.1021 |
| Urea (mmol/l) | 16.49 ± 1.54 | 17.92 ± 1.41 | 17.64 ± 1.15 | 15.71 ± 2.11 | 0.1991 | 0.2449 |
| Creatinine (μmol/l) | 37.13 ± 3.54 | 38.90 ± 4.42 | 35.36 ± 6.19 | 33.59 ± 3.54 | 0.3540 | 0.1713 |
| Glucose (mmol/l) | 7.08 ± 0.11 | 8.05 ± 0.99 | 8.37 ± 1.58 | 6.72 ± 0.72 | 0.0821 | 0.3526 |
| Total protein (mg/dl) | 63.20 ± 1.90 | 59.40 ± 1.50 | 59.80 ± 3.70 | 51.60 ± 27.90 | 0.1738 | 0.2611 |
| Albumin (g/l) | 38.40 ± 2.10 | 33.60 ± 6.30 | 37.60 ± 3.60 | 36.00 ± 20.00 | 0.2944 | 0.2056 |
| Bilirubin (μmol/l) | 0.96 ± 0.51 | 1.30 ± 0.17 | 0.82 ± 0.34 | 0.89 ± 0.51 | 0.2063 | 0.2404 |
| Calcium (mmol/l) | 2.56 ± 0.14 | 2.53 ± 0.12 | 2.60 ± 0.14 | 2.61 ± 0.08 | 0.5739 | 0.1046 |
| Magnesium (mmol/l) | 1.23 ± 0.15 | 1.29 ± 0.14 | 1.29 ± 0.13 | 1.21 ± 0.11 | 0.6106 | 0.0956 |
Values are shown as median ± S.D., P, ɛ2.
Enzymes determined in animals submitted to different treatments
| Enzymes | CG | CHE | VBR | VBR + CHE | ||
|---|---|---|---|---|---|---|
| Amylase (μKat/l) | 0.10 ± 0.00 | 0.10 ± 0.01 | 0.10 ± 0.01 | 0.10 ± 0.01 | 0.4557 | 0.1282 |
| Lipase (μKat/l) | 46.22 ± 25.32 | 46.04 ± 6.12 | 48.53 ± 6.67 | 48.32 ± 6.06 | 0.5098 | 0.1370 |
| CK (μKat/l) | 26.33 ± 8.52 | 25.78 ± 17.32 | 21.99 ± 6.27 | 19.65 ± 9.17 | 0.4456 | 0.1478 |
| ALT (μKat/l) | 2.18 ± 0.32 | 2.54 ± 1.59 | 2.08 ± 0.62 | 2.41 ± 0.84 | 0.5528 | 0.1103 |
| AST (μKat/l) | 1.20 ± 0.12 | 1.23 ± 0.26 | 1.24 ± 0.10 | 1.15 ± 0.15* | 0.0209 | 0.5129 |
| ALP (μKat/l) | 1.82 ± 0.54 | 1.75 ± 0.44 | 1.67 ± 0.21 | 1.44 ± 0.32 | 0.0761 | 0.3616 |
*P<0.05. Values are shown as median ± S.D., P, ɛ2. Abbreviation: μKat, microkatal.